K. Brown and J. Sethna, Statistical mechanical approaches to models with many poorly known parameters, Physical Review E, vol.22, issue.2, 2003.
DOI : 10.1016/0021-9991(76)90078-4

A. Grosdidier, V. Zoete, and O. Michielin, Fast docking using the CHARMM force field with EADock DSS, Journal of Computational Chemistry, vol.28, issue.10, pp.2149-2159, 2011.
DOI : 10.1002/jcc.20634

A. Grosdidier, V. Zoete, and O. Michielin, SwissDock, a protein-small molecule docking web service based on EADock DSS, Nucleic Acids Research, vol.49, issue.12, pp.270-277, 2011.
DOI : 10.1167/iovs.08-2145

D. Gu, L. Mcnaughton, D. Lemaster, B. Lake, N. Gooderham et al., ]pyridine, and Their Metabolites in Human Urine, Chemical Research in Toxicology, vol.23, issue.4, pp.788-801, 2010.
DOI : 10.1021/tx900436m

R. Gutenkunst, J. Waterfall, F. Casey, K. Brown, C. Myers et al., Universally sloppy parameter sensitivities in systems biology models, PLOS Computational Biology, vol.3, issue.10, pp.1871-1878, 2007.

I. Agency, . Research, and . Cancer, Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42 In: IARC monographs on the evaluation of carcinogenic risks to humans Supplement 7. 7. Geneva: World Health Organization, International Agency for Research on Cancer, pp.1-440, 1987.

M. Iwasaki, Y. Yoshimura, S. Asahi, K. Saito, S. Sakai et al., Functional Characterization of Single Nucleotide Polymorphisms with Amino Acid Substitution in CYP1A2, CYP2A6, and CYP2B6 Found in the Japanese Population, Drug Metabolism and Pharmacokinetics, vol.19, issue.6, pp.444-452, 2004.
DOI : 10.2133/dmpk.19.444

P. Josephy, K. Bibeau, and D. Evans, Activation of MeIQ (2-amino-3,4-dimethylimidazo- [4,5-f]quinoline) by sequence variants of recombinant human cytochrome P450 1A2, 4<328::AID-EM7>3.0.CO, pp.328-335, 2000.
DOI : 10.1093/oxfordjournals.jbchem.a022125

T. Kato, H. Ohgaki, H. Hasegawa, S. Sato, S. Takayama et al., ]quinoxaline, Carcinogenesis, vol.9, issue.1, pp.71-73, 1988.
DOI : 10.1093/carcin/9.1.71

M. Krauss, R. Burghaus, J. Lippert, M. Niemi, P. Neuvonen et al., Using Bayesian-PBPK modeling for assessment of inter-individual variability and subgroup stratification, Silico Pharmacology, pp.1-6, 2013.
DOI : 10.1021/jm030999b

L. Kuepfer, C. Niederalt, T. Wendl, J. Schlender, S. Willmann et al., Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model, CPT: Pharmacometrics & Systems Pharmacology, vol.25, issue.e80, pp.516-531, 2016.
DOI : 10.1038/nbt1330

H. Kushida, K. Wakabayashi, H. Sato, M. Katami, R. Kurosaka et al., Dose-response study of MeIQx carcinogenicity in F344 male rats, Cancer Letters, vol.83, issue.1-2, pp.31-35, 1994.
DOI : 10.1016/0304-3835(94)90295-X

S. Langouët, A. Paehler, D. Welti, N. Kerriguy, A. Guillouzo et al., Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rat and human hepatocytes, Carcinogenesis, vol.23, issue.1, pp.115-122, 2002.
DOI : 10.1093/carcin/23.1.115

S. Langouët, D. Welti, N. Kerriguy, L. Fay, T. Huynh-ba et al., ]quinoxaline-8-carboxylic Acid Is a Major Detoxication Pathway Catalyzed by Cytochrome P450 1A2, Chemical Research in Toxicology, vol.14, issue.2, pp.211-221, 2001.
DOI : 10.1021/tx000176e

T. Maiwald and J. Timmer, Dynamical modeling and multi-experiment fitting with PottersWheel, Bioinformatics, vol.6, issue.18, pp.2037-2043, 2008.
DOI : 10.1214/aos/1176344136

Y. Masubuchi, N. Kagimoto, S. Narimatsu, S. Fujita, and T. Suzuki, Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes. Drug Metabolism and Disposition, The Biological Fate of Chemicals, vol.21, issue.6, pp.1012-1016, 1993.

G. Nauwelaers, E. Bessette, D. Gu, Y. Tang, J. Rageul et al., DNA Adduct Formation of 4-Aminobiphenyl and Heterocyclic Aromatic Amines in Human Hepatocytes, Chemical Research in Toxicology, vol.24, issue.6, pp.913-925, 1021.
DOI : 10.1021/tx200091y

URL : https://hal.archives-ouvertes.fr/hal-00609223

W. Ni, L. Mcnaughton, D. Lemaster, R. Sinha, and R. Turesky, Quantitation of 13 Heterocyclic Aromatic Amines in Cooked Beef, Pork, and Chicken by Liquid Chromatography???Electrospray Ionization/Tandem Mass Spectrometry, Journal of Agricultural and Food Chemistry, vol.56, issue.1, pp.68-78, 1021.
DOI : 10.1021/jf072461a

A. Parikh, P. Josephy, and F. Guengerich, Biochemistry, vol.38, issue.17, pp.5283-5289, 1999.
DOI : 10.1021/bi990142+

J. Pritchett, R. Kuester, and I. Sipes, Metabolism of bisphenol a in primary cultured hepatocytes from mice, rats, and humans. Drug Metabolism and Disposition: The Biological Fate of, Chemicals, vol.30, issue.11, pp.1180-1185, 2002.

A. Raue, C. Kreutz, T. Maiwald, J. Bachmann, M. Schilling et al., Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood, Bioinformatics, vol.11, issue.15, pp.1923-1929, 2009.
DOI : 10.1081/PRE-120024426

K. Rich, B. Murray, I. Lewis, N. Rendell, D. Davies et al., -Hydroxy-MeIQx is the major microsomal oxidation product of the dietary carcinogen MeIQx with human liver, Carcinogenesis, vol.13, issue.12, pp.2221-2226, 1992.
DOI : 10.1093/carcin/13.12.2221

W. Stillwell, R. Turesky, R. Sinha, and S. Tannenbaum, N-oxidative metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in humans: excretion of the N2-glucuronide conjugate of 2-hydroxyamino-MeIQx in urine, Cancer Research, vol.59, issue.20, pp.5154-5159, 1999.

S. Sturla and P. Hollenberg, Systems Toxicology: A Special Issue, Chemical Research in Toxicology, vol.27, issue.3, pp.311-321, 2014.
DOI : 10.1021/tx500024u

R. Turesky, F. Guengerich, A. Guillouzo, and S. Langouüt, Metabolism of heterocyclic aromatic amines by human hepatocytes and cytochrome P4501A2, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.506, issue.507, pp.187-195, 2002.
DOI : 10.1016/S0027-5107(02)00165-3

R. Turesky, L. Marchand, and L. , Metabolism and Biomarkers of Heterocyclic Aromatic Amines in Molecular Epidemiology Studies: Lessons Learned from Aromatic Amines, Chemical Research in Toxicology, vol.24, issue.8, pp.1169-1214, 2011.
DOI : 10.1021/tx200135s

R. Turesky, V. Parisod, T. Huynh-ba, S. Langouet, and F. Guengerich, ]quinoxaline by Human and Rat Liver Microsomes and Cytochromes P450 1A2, Chemical Research in Toxicology, vol.14, issue.7, pp.901-911, 1021.
DOI : 10.1021/tx010035s

A. Upthagrove and W. Nelson, Importance of amine pKa and distribution coefficient in the metabolism of fluorinated propranolol analogs: metabolism by CYP1A2. Drug Metabolism and Disposition, The Biological Fate of Chemicals, vol.29, issue.11, pp.1389-1395, 2001.

A. Villaverde and J. Banga, Reverse engineering and identification in systems biology: strategies, perspectives and challenges, Journal of The Royal Society Interface, vol.34, issue.suppl_1, 2014.
DOI : 10.1093/nar/gkj092

R. Yuan, S. Madani, X. Wei, K. Reynolds, and S. Huang, Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions. Drug Metabolism and Disposition: The Biological Fate of, Chemicals, vol.30, issue.12, pp.1311-1319, 2002.

X. Zhuang and C. Lu, PBPK modeling and simulation in drug research and development, Acta Pharmaceutica Sinica B, vol.6, issue.5, pp.430-440, 2016.
DOI : 10.1016/j.apsb.2016.04.004